This guideline covers identifying and managing familial hypercholesterolaemia (FH), a specific type of high cholesterol that runs in the family, in children, young people and adults. It aims to help identify people at increased risk of coronary heart disease as a result of having FH....
Since publication of the seventh American College of Chest Physicians (ACCP) supplement on antithrombotic and thrombolytic therapy, the results of clinical trials have provided important new information on the management of thromboembolic disorders, and the science of developing recommendations has advan...
These guidelines, developed for use in less resourced settings, address the design, production, supply and service delivery of manual wheelchairs, in particular for long-term wheelchair users. The guidelines and related recommendations are targeted at a range of audiences, including policy-makers; planne...
This aim lead to strategies that increase the proportion of adults who participate in adequate physical activity for health-enhancing benefits; lead to policy and programme development that addresses the broader social, physical and policy environments that might support physical activity in populations ...
The first module in the Cancer Control series, Planning, provides a template for cancer control planning and progamme implementation. The recommended framework draws on earlier WHO work in this field, the principles of which are set out in National cancer control programmes, policies and managerial guide...
The Department of Ageing and Life Course (ALC) has developed a toolkit that assists health care workers in being well versed in the diagnosis and management of the chronic diseases and the so-called four giants of geriatrics (memory loss, urinary incontinence, depression and falls/immobility) that often ...
In June 2005, WHO’s Strategic, Technical and Advisory Group on TB approved the
new Stop TB Strategy, which was endorsed by the Stop TB Partnership Coordinating
Board in November 2005. The new Strategy was designed to deal with challenges and obstacles that slow the progress in achieving tuberculosis co...
mhGAP is WHO’s action plan to scale up services for mental, neurological and substance use disorders for countries especially with low and lower middle incomes. The priority conditions addressed by mhGAP are: depression, schizophrenia and other psychotic disorders, suicide, epilepsy, dementia, disorder...
